Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04373148 · ClinicalTrials.gov registry record
Understanding Immunity to SARS-CoV-2, the Coronavirus Causing COVID-19
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 316
- Enrollment target
NCT04373148: Completed study, sponsored by Stanford University.
NCT04373148 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 316 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04373148 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 316 participants
- Enrollment target
Study Summary
The purpose of this study is to test over time immunity to SARS-CoV-2, a recently identified coronavirus responsible for the 2019 world-wide pneumonia outbreak known as COVID-19. Adults and children diagnosed with COVID-19 as well as controls without COVID-19 will be invited to participate in this study.
Interventions
- OTHER There is no intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 316 participants |
| Start Date | 2020-04-08 |
| Est. Completion | 2022-05-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04373148
The ClinicalTrials.gov registry entry for NCT04373148 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 316 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which There is no intervention is the first listed.
NCT04373148 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04373148 about?
NCT04373148 is a clinical study titled "Understanding Immunity to SARS-CoV-2, the Coronavirus Causing COVID-19". The purpose of this study is to test over time immunity to SARS-CoV-2, a recently identified coronavirus responsible for the 2019 world-wide pneumonia outbreak known as COVID-19. Adults and children diagnosed with COVID-19 as well as controls without COVID-19 will be invited to participate in this s...
What is the current status of trial NCT04373148?
This trial is currently completed. The enrollment target is 316 participants. The study started on 2020-04-08. Estimated completion is 2022-05-31.
What interventions are being tested in trial NCT04373148?
The interventions under investigation include: There is no intervention (OTHER).
Who is sponsoring clinical trial NCT04373148?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.